Industry Conference Focused on Overcoming Healthcare Policy, Economic, and Business Hurdles in Go-to-Market Decisioning and Net Revenue Optimization PHILADELPHIA, Sept.…
LEUVEN, Belgium, Sept. 5, 2024 /PRNewswire/ -- P95 BV ("P95"), a leading global provider of epidemiology and clinical solutions with a specialty…
Moderna's updated COVID-19 mRNA vaccine will be available for the 2024-2025 vaccination season, pending a European Commission authorization decision CAMBRIDGE,…
Project Funding Exceeds $7.0 MillionDALLAS, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the…
Ventis Medical Introduces a Technologically Advanced and Affordable Ventilator That Fills an Unmet Need PRINCETON, NJ / ACCESSWIRE / September…
Emmes, part of Emmes Group, today announced they will provide a Clinical Coordinating Center for the NIH's National Institute on…
Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18%Development of a novel antiviral compound, XR8-23 (Compound 10),…
10 patients have been treated to date with azer-cel in the Phase 1b diffuse large B-cell lymphoma (DLBCL) trial Cohort…
CAMBRIDGE, MA / ACCESSWIRE / September 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Taiwan Food & Drug…
- Based on a per-protocol interim analysis of safety and efficacy data, the Independent Data Monitoring Committee (IDMC) recommended that…